EUVIMEDEUVIMED entdecken
Open Access

Portal vein embolization for arterio-portal shunt closure in hepatocellular carcinoma to facilitate selective internal radiation therapy

Xue Liu, Jin-Yan Zhao, Zhen-Yuan Xu, Shu-Qun Shen, Zhi-Jia Xu, Ye-Fa Yang, Nai-Jian Ge, Xiang-Dong Wang

World Journal of Radiology · 28.07.2026 · 18 (7)

DOI: 10.4329/wjr.121348 ↗

Kurz gefasst

Fachartikel in der Zeitschrift World Journal of Radiology, online erschienen am 28.07.2026. Verfasst von Xue Liu und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Interventional Radiology, Shanghai Eastern Hepatobiliary Surgery Hospital, Shanghai 200438, China. Die Arbeit nennt 28 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND Selective internal radiation therapy (SIRT) has been widely used in the treatment of hepatocellular carcinoma (HCC). However, marked intrahepatic shunt (IHS) secondary to arterio-portal shunt (APS) often precludes safe SIRT administration. AIM To evaluate the efficacy and safety of portal vein embolization (PVE) in reducing IHS and enabling SIRT therapy in HCC patients with APS. METHODS This retrospective study enrolled seven HCC patients with APS confirmed by hepatic angiography during mapping. PVE was performed to close the APS outlet and single photon emission computed tomography/computed tomography was performed to determine the distribution of (99m) technetium-labeled macroaggregated albumin. These patients meeting the criteria for SIRT subsequently underwent Yttrium-90 (Y-90) resin microspheres administration. Changes in liver function and complications were monitored during the 6-month follow-up period. RESULTS Complete APS occlusion was achieved in six patients (n = 6, 6/7). The hepatopulmonary shunt rate was below 20% (4.65%-16.95%) in five of six patients with APS occluded, and Y-90-SIRT was subsequently administered in these patients. No severe procedural complications occurred. CONCLUSION PVE is a safe and effective strategy to reduce IHS in HCC patients with APS, thereby improving eligibility for SIRT.

Schlagwörter

Stichwörter der Autor:innen

Arterio-portal shuntHepatocellular carcinomaHepatopulmonary shuntMacroaggregated albuminPortal vein embolizationSelective internal radiation therapy

Autor:innen und Institutionen

  • Department of Interventional Radiology, Shanghai Eastern Hepatobiliary Surgery Hospital, Shanghai 200438, China.
  • Department of Laboratory Medicine, Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai 200080, China.
  • Department of Interventional Radiology, Shanghai Eastern Hepatobiliary Surgery Hospital, Shanghai 200438, China. 15502106056@163.com.

Zitieren

APA

Liu, X., Zhao, J. Y., Xu, Z. Y., Shen, S. Q., Xu, Z. J., Yang, Y. F., Ge, N. J., & Wang, X. D. (2026). Portal vein embolization for arterio-portal shunt closure in hepatocellular carcinoma to facilitate selective internal radiation therapy. World Journal of Radiology, 18(7). https://doi.org/10.4329/wjr.121348

Vancouver

Liu X, Zhao JY, Xu ZY, Shen SQ, Xu ZJ, Yang YF, et al. Portal vein embolization for arterio-portal shunt closure in hepatocellular carcinoma to facilitate selective internal radiation therapy. World Journal of Radiology. 2026;18(7). doi:10.4329/wjr.121348

BibTeX
@article{Liu2026,
  author = {Liu, Xue and Zhao, Jin-Yan and Xu, Zhen-Yuan and Shen, Shu-Qun and Xu, Zhi-Jia and Yang, Ye-Fa and Ge, Nai-Jian and Wang, Xiang-Dong},
  title = {Portal vein embolization for arterio-portal shunt closure in hepatocellular carcinoma to facilitate selective internal radiation therapy},
  journal = {World Journal of Radiology},
  year = {2026},
  volume = {18},
  number = {7},
  doi = {10.4329/wjr.121348}
}
Kostenlos starten →